Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penyanxiao
- Development stage
- Preclinical
- Administration
- Pelvic Perfusion
01
Overview
Penyanxiao is a traditional Chinese medicine (TCM) formulation used in the treatment of sequelae of pelvic inflammatory disease (PID), particularly in patients diagnosed with the TCM syndrome of "accumulated damp heat." It is typically administered as part of combination therapy, such as with pelvic perfusion. The precise herbal composition, mechanism of action, and pharmacological targets are not specified in available sources. Its use is based on TCM principles rather than Western pharmacology, and it is being studied for its effects on immune molecular mechanisms related to PID sequelae[1].
- Brand names
- Penyanxiao
- Other names
- Penyanxiao
Beyond the preview
Go deeper on Penyanxiao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Penyanxiao.